Active Ingredient History
Avelumab, sold under the brand name Bavencio, is a fully human monoclonal antibody medication for the treatment of Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adenocarcinoma (Phase 1)
Antineoplastic Agents (Phase 2)
Biliary Tract Neoplasms (Phase 1/Phase 2)
Biomarkers (Phase 2)
Bone Marrow Diseases (Phase 2)
BRCA1 Protein (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 1/Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Neuroendocrine (Phase 1/Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 3)
Central Nervous System Neoplasms (Phase 1)
Cholangiocarcinoma (Phase 1/Phase 2)
Chordoma (Phase 1/Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 2)
Dermatology (Phase 1/Phase 2)
DNA Mismatch Repair (Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 3)
Fallopian Tube Neoplasms (Phase 2)
Fibrosarcoma (Phase 1)
Gallbladder Neoplasms (Phase 1/Phase 2)
Gastrointestinal Stromal Tumors (Phase 1/Phase 2)
Genes, erbB-2 (Phase 2)
Gestational Trophoblastic Disease (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Gonadal Disorders (Phase 2)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Hodgkin Disease (Phase 2)
Kidney Neoplasms (Phase 2)
Laryngeal Neoplasms (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Liposarcoma (Phase 1/Phase 2)
Lung Diseases (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Melanoma (Phase 2)
Meninges (Phase 1)
Meningioma (Phase 1)
Mesothelioma (Phase 1/Phase 2)
Microsatellite Instability (Phase 3)
Multiple Myeloma (Phase 2)
Mutation (Phase 2)
Mycosis Fungoides (Phase 1)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 1/Phase 2)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Second Primary (Phase 2)
Neuroendocrine Tumors (Phase 2)
Osteosarcoma (Phase 2)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 2)
Papillomaviridae (Phase 2)
Penile Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 1)
Prostatic Neoplasms (Phase 2)
ras Proteins (Phase 2)
Rectal Neoplasms (Phase 2)
Sarcoma (Phase 1/Phase 2)
Sezary Syndrome (Phase 1)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Stomach Neoplasms (Phase 3)
Testicular Diseases (Phase 2)
Testicular Neoplasms (Phase 2)
Thymoma (Phase 2)
Thyroid Neoplasms (Phase 1/Phase 2)
Triple Negative Breast Neoplasms (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 2)
Vulvar Neoplasms (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
